<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Yoni Cheifetz on Medium]]></title>
        <description><![CDATA[Stories by Yoni Cheifetz on Medium]]></description>
        <link>https://medium.com/@YoniCheifetz_27027?source=rss-34001810662c------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*p-KIiEkAkU22tjDfPRP_gw.png</url>
            <title>Stories by Yoni Cheifetz on Medium</title>
            <link>https://medium.com/@YoniCheifetz_27027?source=rss-34001810662c------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Tue, 17 Nov 2026 17:29:18 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@YoniCheifetz_27027/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[The $100 genome will change medicine, from disease diagnosis to treatment]]></title>
            <link>https://medium.com/lightspeed-venture-partners/the-100-genome-will-change-medicine-from-disease-diagnosis-to-treatment-3ddc0b5c5fae?source=rss-34001810662c------2</link>
            <guid isPermaLink="false">https://medium.com/p/3ddc0b5c5fae</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[founders]]></category>
            <category><![CDATA[genomics]]></category>
            <category><![CDATA[venture-capital]]></category>
            <dc:creator><![CDATA[Yoni Cheifetz]]></dc:creator>
            <pubDate>Tue, 31 May 2022 13:06:03 GMT</pubDate>
            <atom:updated>2022-05-31T13:06:03.922Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*3LodGJ0ZbWu5NUk8RZM6iw.jpeg" /><figcaption>Gilad Almogy, CEO, Ultima Genomics</figcaption></figure><h4><em>Why Lightspeed’s investment in Ultima Genomics is a win for patient care</em></h4><p>By Yoni Cheifetz and <a href="https://medium.com/u/9925aa12e298">Jonathan Macquitty</a></p><p>When someone is diagnosed with cancer, their doctor will often order a biopsy of the tumor. That tissue will then be screened for a select set of genetic markers, such as BRCA, HER2, and PARP, which will inform what treatments may work best to attack the cancer. Once a patient is in remission, they’ll receive MRI or PET scans twice a year to spot any recurring tumors.</p><p>Ultima Genomics and its sequencing technology could change that entire process.</p><p>Led by CEO Gilad Almogy, Ultima Genomics has developed a new approach to sequencing that drives down costs and increases throughput so that the entire human genome can be sequenced for just $100.</p><p>Although sequencing is already a staple in medical research and care, its wide application is currently limited by cost. Dozens of companies offer genetic sequencing panels that will look at 50, 100, or even 500 genes — but that’s a drop in the bucket considering the 20,000 genes in the human genome. Doctors and researchers are forced to pick and choose which genes to include on panels, because including any more would be a hefty cost increase.</p><p>By unlocking the $100 genome, Ultima Genomics will ensure that improving a patient’s health with genetic sequencing is no longer cost prohibitive.</p><p>That’s why today we are pleased to destealth Ultima Genomics and its new sequencing technology. Lightspeed Venture Partners co-led the seed round along with Khosla Ventures and has continued to provide significant support to the company across multiple rounds of investments. This has culminated in over $600 million in total current funding. In addition, Lightspeed has provided strategic advice and introductions to help the company build and grow its business.</p><h4><strong>A smart investment</strong></h4><p>In addition to potential impact for patients, Lightspeed looks for big ideas from smart founders in markets where it is hard for others to compete, and Ultima Genomics checks all the boxes.</p><p>When Lightspeed first invested in Ultima Genomics’ seed round, sequencing the entire human genome was priced at around $1,000. The company is making that possible at a tenth of the price. Furthermore, with its new technology, the company plans to reduce costs even further in the future.</p><p>The market is ripe for a new sequencing player to enter the scene; the market opportunity is valued at roughly $5 billion and growing, with only one major competitor. There are other players in the sequencing field, but they’re focused on smaller benchtop machines for researchers, not the high-throughput applications Ultima Genomics is targeting.</p><h4><strong>What the $100 genome means for medicine</strong></h4><p>Ultima Genomics’ genetic sequencing technology is a tool that can vastly improve our understanding of human health and fuel true precision medicine.</p><p>With regards to cancer diagnosis and treatment, the $100 genome will revolutionize the care ecosystem. Frequent monitoring with low-cost sequencing will help physicians spot cancer earlier, select the most effective treatment, and — most importantly — capture disease recurrence as soon as possible.</p><p>MRI or PET scans can only detect tumors once they’ve grown big enough to be visible. By that point, it’s often too late to take meaningful action. But if the tumor’s genome is sequenced and you obtain its unique genetic signature, physicians can look for signs of this signature in routine blood draws. Sequencing is a less burdensome, more accurate option to detect recurrence, and Ultima Genomics is making frequent monitoring by sequencing affordable for the rest of a patient’s life.</p><p>Low-cost genetic sequencing can also be applied to population studies to shed light on more complex diseases that often cannot be attributed to just one or a few key genetic mutations as their root causes. Certain mental illness, heart disease, and obesity fall within this category, where we know a genetic link exists because disease manifestations correlate with family histories. However, we cannot identify the responsible elements within the human genome.</p><p>That’s because each human genome is very complex, totaling three billion bases that are further complicated by epigenomic modifications on subsets of the bases. One person’s genome doesn’t give much insight into what element within their genome is responsible for a symptom, much less extrapolate the limited insight to another individual with a similar symptom — identifying the genetic signatures for a multitude of complex diseases will require sequencing thousands of genetic codes across populations.</p><p>Widespread population studies that can reveal links between genetics, environments and diseases are now possible, thanks to the emergence of biobanks in digital healthcare, advances in machine learning, and the debut of Ultima Genomics’ affordable genetic sequencing platform.</p><p>Costs, not technical innovations, have prevented true precision medicine from being applied at scale. Thanks to Ultima Genomics, sequencing technology that was previously expensive will be made affordable, and a new generation of precision medicines will be accessible to more patients.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3ddc0b5c5fae" width="1" height="1" alt=""><hr><p><a href="https://medium.com/lightspeed-venture-partners/the-100-genome-will-change-medicine-from-disease-diagnosis-to-treatment-3ddc0b5c5fae">The $100 genome will change medicine, from disease diagnosis to treatment</a> was originally published in <a href="https://medium.com/lightspeed-venture-partners">Lightspeed Venture Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Lightspeed invests in Herald to take the pain out of digitizing insurance]]></title>
            <link>https://medium.com/lightspeed-venture-partners/lightspeed-invests-in-herald-to-take-the-pain-out-of-digitizing-insurance-b19baba5e3c3?source=rss-34001810662c------2</link>
            <guid isPermaLink="false">https://medium.com/p/b19baba5e3c3</guid>
            <category><![CDATA[fintech]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[digital-infrastructure]]></category>
            <category><![CDATA[insurance]]></category>
            <category><![CDATA[insurtech]]></category>
            <dc:creator><![CDATA[Yoni Cheifetz]]></dc:creator>
            <pubDate>Wed, 15 Dec 2021 15:02:53 GMT</pubDate>
            <atom:updated>2021-12-15T15:07:24.938Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*atwNErYz38nrOewAnjc1Mg.jpeg" /><figcaption>Herald Co-Founders Duncan Crystal and Matt Antoszyk.</figcaption></figure><p>Over the last five years, Fintech has exploded. The growth of new software and services has continued to attract investment, leading to $91.5 billion in <a href="https://www.forbes.com/sites/isabelcontreras/2021/10/18/fintech-investments-have-hit-915-billion-in-2021-nearly-doubling-last-years-total/?sh=7253884d4a2e">global funding</a> this year, nearly 2x last year. Insurtech is about to follow a similar trajectory, thanks to digital infrastructure startups like <a href="https://www.heraldapi.com/">Herald</a>.</p><p>Today, matching the hundreds of insurance carriers with the tens of thousands of small and medium size businesses that distribute insurance is a tedious process that’s both expensive and error prone. Brokers must manually input information about their customers into each insurer’s format, wait for a quote to come back describing coverages and costs, then help the SMB decide which carrier to use. Or they must build and maintain separate integrations with each carrier, a complex and time-consuming technical challenge.</p><p>Herald automates this process by connecting directly to multiple insurance carriers, making it easier for brokers to obtain quotes for their SMB customers. Brokers fill out a single form, and Herald does the rest. Even when insurers don’t offer their own application programming interfaces, Herald can extract the relevant information from the carrier’s websites.</p><p>Herald addresses a major pain point for the nearly US$300 billion commercial insurance industry, which is why Lightspeed is excited to lead <a href="https://www.businesswire.com/news/home/20211215005136/en/Herald-Raises-8-Million-in-Seed-Funding-to-Build-Digital-Infrastructure-for-Commercial-Insurance">the company’s new $8 million funding round</a>, alongside Underscore and Afore Capital, as well as angel investors Garrett Koehn, Rotem Iram, and Charley Ma.</p><p><strong>A Strong Foundation</strong></p><p>Our interest in unlocking innovation in the insurance space goes back six years to our original investments in <a href="https://lsvp.com/portfolio/ladder/">Ladder</a> and <a href="https://lsvp.com/portfolio/at-bay/">At-Bay</a>, now valued at <a href="https://techcrunch.com/2021/10/04/ladder-raises-100m-on-a-900m-valuation-for-a-platform-selling-flexible-term-life-insurance/">$900 million</a> and <a href="https://www.bizjournals.com/sanjose/news/2021/07/27/cyber-insurance-startup-at-bay-raises-185m.html">$1.3 billion</a>, respectively. We’ve gained key insights into the underlying tech challenges facing the industry, and so has Herald’s founding team.</p><p>CEO Matt Antoszyk was At-Bay’s first product manager, as well as a former senior business analyst at McKinsey. CRO Duncan Crystal was also one of At-Bay’s earliest employees, managing business development, partnerships, and the API product. Prior to that, he served as a senior strategy analyst at Gartner. CTO Jacob Barnett was an engineering manager at Haven Life Insurance who helped build the carrier’s core rating and quoting experience technology.</p><p>These three leaders bring strong technical backgrounds and deep connections to the insurance ecosystem. We’re very familiar with Matt and Duncan from their work with At-Bay, and are confident they will excel as entrepreneurs.</p><p><strong>A Greenfield Opportunity</strong></p><p>The insurance industry is really just starting to experience its digital transformation, making Insurtech a greenfield opportunity with an enormous potential market. Starting in commercial insurance, Herald plans to expand to additional markets, and anticipates expanding beyond automating quote requests to other insurance transactions, such as buying, billing, renewals, and claims.</p><p>The company’s earliest customer, BindHQ, reports time savings of more than 30 minutes per applicant using Herald technology. As the number of customers grows, we believe the company will experience a network effect: Insurers connected via the API will push more brokers to adopt the company’s solutions, and vice versa.</p><p>Commercial insurance is a low-margin, high-volume business desperately in need of automated solutions. Like Stripe and Plaid in the Fintech space, Herald provides digital infrastructure that enables insurance carriers to operate more seamlessly, eliminating much of the friction generated by traditional business processes. We believe the company will become a cornerstone in the growing Insurtech ecosystem.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b19baba5e3c3" width="1" height="1" alt=""><hr><p><a href="https://medium.com/lightspeed-venture-partners/lightspeed-invests-in-herald-to-take-the-pain-out-of-digitizing-insurance-b19baba5e3c3">Lightspeed invests in Herald to take the pain out of digitizing insurance</a> was originally published in <a href="https://medium.com/lightspeed-venture-partners">Lightspeed Venture Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Outbrain’s IPO: A smart idea, a long time coming]]></title>
            <link>https://medium.com/lightspeed-venture-partners/outbrains-ipo-a-smart-idea-a-long-time-coming-6d879e3a347b?source=rss-34001810662c------2</link>
            <guid isPermaLink="false">https://medium.com/p/6d879e3a347b</guid>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[ipo]]></category>
            <category><![CDATA[israel]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[lightspeedglobal]]></category>
            <dc:creator><![CDATA[Yoni Cheifetz]]></dc:creator>
            <pubDate>Fri, 23 Jul 2021 15:46:01 GMT</pubDate>
            <atom:updated>2021-07-23T17:07:01.350Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Ar8MXC6uRfamh11CkGj2KA.png" /></figure><p>By now we’ve all grown used to machines serving up recommendations for movies to watch, products to buy, food to eat, or things to do. Sometimes it seems like the algorithms know us better than we know ourselves.</p><p>But it wasn’t always that way. Back in 2006 Netflix was still shipping DVDs to peoples’ homes. Amazon Prime was barely a year old. And Outbrain had just launched in Israel.</p><p>If you’ve ever read the news on your laptop or mobile device, you’ve seen Outbrain. It’s what creates related stories around all types of content, personalized to your interests. Every day, Outbrain reaches more than 1 billion people across the globe, but when the company began in 2006, it was a true pioneer in content discovery. Since then it’s been imitated, but never truly equaled.</p><p>As an early investor I was drawn to the idea that great content recommendations will increase user engagement and, in return, drive monetization. This concept, along with confidence in the company’s founders, convinced Lightspeed to participate in the seed round and all following rounds.</p><p>It’s been an amazing journey, and I feel privileged to have seen it unfold from the beginning. I am especially proud to congratulate the Outbrain team on their initial public offering today.</p><h4><strong>Why Outbrain?</strong></h4><p>Outbrain was founded on a simple principle: The more people consume content that they like, the more content they are likely to consume, increasing engagement and monetization.</p><p>By delivering personalized content recommendations to audiences, Outbrain has been able to generate more than $3 billion in revenue for the world’s largest media companies, including CNN, MSN, the Washington Post, Conde Nast, Sky News, LeMonde, and many more.</p><p>In a market dominated by Google and Facebook, Outbrain has become a vital resource for publishers to generate revenue independent of the two giants.</p><p>But getting content discovery right is not a trivial problem to solve. Adopting this once-radical approach to optimize for engagement required deep technological expertise, which Outbrain brought in the form of its two founders, co-CEO Yaron Galai and CTO Ori Lahav.</p><p>Today, the Outbrain Cloud relies on a proprietary, microservices architecture embedded via APIs into publishers’ content delivery systems. It processes more than 1 billion data signals in realtime to deliver 100 million content predictions per second, ultimately resulting in more than 40 million consumer engagements each day.</p><p>Outbrain has become the de-facto operating system for open web media owners. Partnerships with publishers, media brands and advertisers are have expanded, with click-through rates and revenue growing correspondingly.</p><p>Yet, despite the tremendous changes we’ve seen in the 15 years since the company launched, Outbrain itself has remained remarkably stable. Yaron and Ori, who originally met when both served in the Israeli navy, continue to run the company along with co-CEO David Kostman. Every member of its leadership team has been with the company for seven years or more.</p><h4><strong>From Tel Aviv, with love</strong></h4><p>Lightspeed has been investing in early-through-growth-stage Israeli-based companies for more than a decade, and Outbrain is one of several major public offerings to come out of Israel over the past month.</p><p>Becoming a public company is an epic milestone for any business. My warmest congratulations to Yaron, Ori, David, and the rest of the amazing Outbrain team on this achievement.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=6d879e3a347b" width="1" height="1" alt=""><hr><p><a href="https://medium.com/lightspeed-venture-partners/outbrains-ipo-a-smart-idea-a-long-time-coming-6d879e3a347b">Outbrain’s IPO: A smart idea, a long time coming</a> was originally published in <a href="https://medium.com/lightspeed-venture-partners">Lightspeed Venture Partners</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Bullish on Israel]]></title>
            <link>https://medium.com/@YoniCheifetz_27027/bullish-on-israel-387f3fb7c6c?source=rss-34001810662c------2</link>
            <guid isPermaLink="false">https://medium.com/p/387f3fb7c6c</guid>
            <category><![CDATA[founders]]></category>
            <category><![CDATA[startup]]></category>
            <category><![CDATA[entrepreneurship]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[israeli-startups]]></category>
            <dc:creator><![CDATA[Yoni Cheifetz]]></dc:creator>
            <pubDate>Tue, 06 Dec 2016 23:31:04 GMT</pubDate>
            <atom:updated>2016-12-06T23:31:04.855Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*x62QyDubW_dZ_lSAP5GteA.png" /><figcaption>Lightspeed Israel offices.</figcaption></figure><p>Lightspeed has been investing in Israeli tech companies for the last 20 years, with Israeli partners (<a href="http://lsvp.com/team/david-gussarsky/">Dudu</a> &amp; me) on the ground since 2006. We invest in Israel out of our global fund (a new $1.2B fund), with our investments in Israeli companies meeting the same high investment bar as the companies we invest in out of Silicon Valley and around the globe.</p><p>We have been generating solid returns from Israeli companies and have a strong portfolio in the consumer, enterprise and digital health sectors. In the last four months alone we have made four investments in Israeli tech companies, ranging from a $2M lead of a $3.5M seed, to a $20M lead in a $32M growth round. And we are seeing a healthy deal pipeline with more to come.</p><p><strong>To further solidify our focus on Israel, we have brought on board Tal Morgenstern as a third partner in Israel. Please join us in welcoming Tal to the Lightspeed team. </strong>(You can read more about Tal’s new role over here in his post: <a href="https://medium.com/@talmorgenstern/hello-lightspeed-farewell-sequoia-f04b1e9eaa61#.be34nss9m"><em>Hello Lightspeed</em></a>.)</p><p>It was important for us to bring on board a mature adult (Tal) that could supervise the two youngsters (Dudu &amp; me) running around and writing checks. ;) But in all seriousness, in our search to bring on board the next generation of Lightspeed talent in Israel, we met many people. We scheduled coffee with Tal to consult with him about peers that he knows who could be good candidates. And at the end of the meeting, when we understood there could be an opportunity to bring Tal on board, we pounced on it! (That’s what you learn as a VC…hunt for the great opportunities and go after them!). Several additional meetings with the rest of the Lightspeed team, and here we are.</p><p>Tal, in addition to being a great investor, is just an all around great guy. He will continue to expand the Lightspeed investment portfolio and brand in Israel as part of the team, and on both a personal and professional level, we are thrilled to have him on board.</p><p>Welcome aboard Tal!</p><p>Yoni &amp; Dudu</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=387f3fb7c6c" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>